---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-004031"
form_type: "8-K"
ticker: "NTRB"
cik: "0001676047"
company_name: "NutriBand Inc."
filed_at: "2022-01-27T23:59:59+00:00"
generated_at: "2026-06-27T15:00:22.384521+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Nutriband expands AVERSA abuse-deterrent pipeline to include buprenorphine and methylphenidate

## Summary
- Adds AVERSA buprenorphine and AVERSA methylphenidate (ADHD) to pipeline; lead product AVERSA Fentanyl has $80-200M potential US sales.
- CEO Gareth Sheridan and President Serguei Melnik sign 3-year employment agreements at $250k base salary; CFO Gerald Goodman at $210k.
- Board grants stock options: Sheridan and Melnik each receive 20,000 shares at $5.34; 13 others get options at $4.85 or $5.34.
- Irina Gram-Contulescu elected as new director; annual meeting also ratified auditor Sadler Gibb and approved 2021 Stock Option Plan.
- By-laws amended to create CEO role and extend annual meeting window from 6 to 12 months after fiscal year-end.

## SEC filing metadata
- accession: 0001213900-22-004031
- form_type: 8-K
- ticker: NTRB
- cik: 0001676047
- company_name: NutriBand Inc.
- filed_at: 2022-01-27T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 5.03, 5.07, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1676047/000121390022004031/0001213900-22-004031-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1676047/000121390022004031/ea154565-8k_nutriband.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-004031
- JSON: https://secwatch.observer/filing/0001213900-22-004031.json
- Plain text: https://secwatch.observer/filing/0001213900-22-004031.txt

## Key facts
- Executive change
  Irina Gram-Contulescu was elected as Director at NutriBand Inc..
  - Action: elected
  - Role: Director
  source text: Irina Gram-Contulescu, 34, was elected as a director of the Company at the January 21, 2022 stockholders meeting.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1676047/000121390022004031/0001213900-22-004031-index.htm
- Executive change
  Serguei Melnik was appointed as Chairman of the Board at NutriBand Inc..
  - Action: appointed
  - Role: Chairman of the Board
  source text: Serguei Melnik, a Board member, President and Secretary of the Company, was also appointed Chairman of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1676047/000121390022004031/0001213900-22-004031-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.